Maternal Vitamin D Supplementation and Offspring Risk of Atopic Eczema

A recent placebo-controlled, double-blind, randomized trial concluded that maternal supplementation with 1000 IU vitamin D daily from 14 weeks gestation to delivery led to a reduced incidence of atopic eczema for babies in their first year of life.

Read the full study- https://onlinelibrary.wiley.com/doi/10.1111/bjd.21721

SOLIUS® devices are not cleared or approved for the indication to treat and/or prevent atopic eczema and/or other skin conditions. SOLIUS devices are intended only to stimulate the production of endogenous vitamin D for the treatment and prevention of vitamin D deficiency. Please review the important safety information associated with SOLIUS therapy.